Search - tctmd.com

Displaying 1 - 20 of 310

Sort: Relevancy | Date

News Daily News

FDA Approves JenaValve’s Trilogy for Aortic Regurgitation

Michael O'Riordan

March 23, 2026

Presentation THT 2026

Real World Databases: What Is Required for Their Use To Substitute for Randomized Trials for Device Approvals, Reimbursement and Label Expansion

Presenter: Robert W. Yeh

March 04, 2026

News Opinion CV Team Dispatch

February 2026 Dispatch for the CV Team

L.A. McKeown

February 18, 2026

News Daily News

Side Effects of Statins Might Be Overstated: CTT Collaboration

Michael O'Riordan

February 12, 2026

News Conference News STS 2026

‘Concerning’ Trends Seen in Aortic Stenosis-Related Mortality: CDC WONDER

Yael L. Maxwell

February 10, 2026

News Opinion CV Team Dispatch

January 2026 Dispatch for the CV Team

L.A. McKeown

January 16, 2026

News Daily News

Year in Review: Structural Heart in 2025 Features EARLY TAVR, Tricuspid Nuance, Mitral Gains

Caitlin E. Cox

December 31, 2025

News Daily News

Volt Pulsed-Field Ablation System Gains FDA Approval

Todd Neale

December 24, 2025

News Daily News

FDA Approves Sapien M3 for Transseptal Mitral Valve Replacement

Michael O'Riordan

December 23, 2025

News Daily News

Etripamil Nasal Spray Gains FDA Approval for Acute Paroxysmal SVT

Todd Neale

December 15, 2025

News Daily News

FDA Approves Lerodalcibep for Adults With Hypercholesterolemia

Yael L. Maxwell

December 15, 2025

Presentation TCT 2025

Regulatory Approvals for Therapies for Patients with “Not Suitable for Conventional Therapy?"

Presenter: Jeffrey Popma

October 28, 2025

News Daily News

Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients

Caitlin E. Cox

October 22, 2025

News Daily News

New ACC Consensus Document Helps Clinicians Navigate Issues Around TR

Todd Neale

September 26, 2025

FDA Expands Evolut Indication to Include Redo TAVI

News Daily News

FDA Expands Evolut Indications to Include Redo TAVI

Yael L. Maxwell

August 29, 2025

News Daily News

Evolocumab Gains Expanded Indication for Primary Prevention

Michael O'Riordan

August 26, 2025

News Daily News

Inclisiran Gains Indication as Stand-alone Therapy to Reduce LDL Cholesterol

Michael O'Riordan

August 06, 2025

News Daily News

FDA Approves Finerenone for HF Patients With Mildly Reduced or Preserved EF

Caitlin E. Cox

July 14, 2025

News Daily News

FDA Approves Triple Therapy Polypill for High Blood Pressure

Michael O'Riordan

June 10, 2025

Advertisement

FDA Approves JenaValve’s Trilogy for Aortic Regurgitation

Real World Databases: What Is Required for Their Use To Substitute for Randomized Trials for Device Approvals, Reimbursement and Label Expansion

February 2026 Dispatch for the CV Team

Side Effects of Statins Might Be Overstated: CTT Collaboration

‘Concerning’ Trends Seen in Aortic Stenosis-Related Mortality: CDC WONDER

January 2026 Dispatch for the CV Team

Year in Review: Structural Heart in 2025 Features EARLY TAVR, Tricuspid Nuance, Mitral Gains

Volt Pulsed-Field Ablation System Gains FDA Approval

FDA Approves Sapien M3 for Transseptal Mitral Valve Replacement

Etripamil Nasal Spray Gains FDA Approval for Acute Paroxysmal SVT

FDA Approves Lerodalcibep for Adults With Hypercholesterolemia

Regulatory Approvals for Therapies for Patients with “Not Suitable for Conventional Therapy?"

Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients

New ACC Consensus Document Helps Clinicians Navigate Issues Around TR

FDA Expands Evolut Indications to Include Redo TAVI

Evolocumab Gains Expanded Indication for Primary Prevention

Inclisiran Gains Indication as Stand-alone Therapy to Reduce LDL Cholesterol

FDA Approves Finerenone for HF Patients With Mildly Reduced or Preserved EF

FDA Approves Triple Therapy Polypill for High Blood Pressure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content